HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

Prostatic Acinar Adenocarcinoma Treatments in NJ, CT, MA, and the Washington, D.C., Area

Prostatic acinar adenocarcinoma is the most common form of prostate cancer, which makes it one of the best understood types of the disease. Patients with this prostate cancer type have a strong chance of successful treatment if their condition is detected early.

Regional Cancer Care Associates (RCCA) treats a variety of cancer types, including breast, lung, colon, and prostate cancers, in addition to a range of malignant and benign blood disorders. We are an authority on cancer care in New Jersey, Connecticut, Massachusetts, and the Washington, D.C., area. With more than 20 locations throughout the region, we allow patients to receive cutting-edge care close to home.

What Is Prostatic Acinar Adenocarcinoma?

Prostatic acinar adenocarcinoma is a form of prostate cancer that forms in the epithelial (protective) cells found in glandular tissue. Acinar adenocarcinoma develops in the gland itself, differentiating it from prostatic ductal adenocarcinoma, which develops in the ducts.

Like other types of cancer, prostate cancer is caused by abnormal cell growth. Under normal conditions, cells reproduce at a consistent rate. Occasionally, however, a mutation alters the molecular instructions that tell cells when to divide. The mutated cells multiply much more quickly than normal. This creates a mass of abnormal cells, or a tumor, that grows and may spread to healthy tissue. The spread is what makes cancer dangerous.

Prostate cancer is among the most common types of cancer affecting men. About one in eight, or 12%, of men will develop prostate cancer at some point in their lives. This makes it second only to skin cancer in terms of cancers diagnosed in men. Almost all new cases are prostatic acinar adenocarcinoma. It is currently estimated that adenocarcinomas account for more than 95% of all prostate cancer cases. Of these, about 90% are prostatic acinar adenocarcinoma.

Patient and oncologist discussing prostate cancer diagnosis

Stages of Prostatic Acinar Adenocarcinoma and Patient Outlook

Cancer is progressive, meaning symptoms get worse over time. Prostate cancer stages are used to describe the progress of the disease. Staging is based on the size of the tumor, how far it has spread, and how much it has increased prostate-specific antigen (PSA) levels in the blood. In summary:

  • Stage I: The tumor is located only in the prostate gland and is too small to be felt during a rectal exam. PSA levels are below 20 ng/mL.
  • Stage II: The tumor is located only in the prostate gland and may be felt during a rectal exam or seen on a sonogram. PSA levels measure between 10 and 20 ng/mL.
  • Stage III: The tumor extends beyond the walls of the prostate gland and may have invaded the seminal vesicle. PSA levels measure above 20 ng/mL.
  • Stage IV: Cancer cells have spread (metastasized) to lymph nodes and other parts of the body, such as the bones, lungs, or liver.

As with other cancers, survival rates are best in the early stages of the disease. Nearly 100% of patients with Stage I, II, and III prostate cancer will survive for at least five years, with most surviving much longer. In Stage IV disease, however, the five-year relative survival rate decreases to 30%. This is why early diagnosis of prostatic acinar adenocarcinoma is so important.

Signs and Symptoms of Prostatic Acinar Adenocarcinoma

Prostatic acinar adenocarcinoma does not always cause symptoms in its early stages. As the cancer develops, however, the growing tumor may interfere with normal prostate function. It may also place pressure on the urinary duct. This can result in the following symptoms:

  • Frequent or urgent urination
  • Slow, interrupted, or inconsistent urine streams
  • Straining during urination
  • Loss of bladder control
  • Pain during urination
  • Blood in urine or semen
  • Erectile dysfunction
  • Pain during ejaculation or sexual activity
  • Rectal pain or pressure

Late-stage prostatic acinar adenocarcinoma may cause symptoms in other parts of the body as cancer cells spread. Patients may experience bone pain, nerve dysfunction, fatigue, and loss of appetite.

Diagnostic Tests for Prostatic Acinar Adenocarcinoma

Due to the lack of symptoms, early-stage prostate cancer can be difficult to identify. Most cases are detected with routine prostate-specific antigen (PSA) screening. After screening detects an abnormality, a urologist or medical oncologist typically will follow these steps to confirm a diagnosis:

Digital Rectal Exam

A digital rectal exam (DRE) involves the physician inserting a gloved, lubricated finger into the rectum. The doctor will feel for lumps or hard masses that could indicate a tumor. While a DRE can assist in detecting later-stage cancer, physicians cannot always feel prostatic acinar adenocarcinoma in its early stages.

Medical Imaging

The oncology team may request an X-ray, computed tomography (CT) scan, magnetic resonance imaging (MRI) scan, or ultrasound. Imaging tests allow a closer look at internal bodily structures and can be used to check for tumors, abnormal tissue, and other signs of prostatic acinar adenocarcinoma.

Prostate Biopsy

Almost all diagnoses are confirmed with a prostate biopsy. For this test, physicians use a hollow needle to remove a small tissue sample. The sample is examined under a microscope to determine whether it contains cancerous cells, how many there are, and how likely they are to respond to certain treatments.

Active Surveillance for Prostatic Acinar Adenocarcinoma

Active surveillance, also called watchful waiting, is an approach urologists and oncologists sometimes take for early-stage, non-aggressive prostate cancer. It involves simply monitoring the cancer to ensure it does not grow. This treatment plan is most often recommended for tumors are not causing health problems. It may also be recommended for elderly patients or those with other health issues.

Treatments for Prostatic Acinar Adenocarcinoma

The RCCA team works closely with a patient and his other physicians to identify and implement the best approach for that person. Specialists consider a variety of factors to develop a personalized treatment plan, prioritizing targeted therapies whenever possible. Options include:

Find Prostate Cancer Treatment Near You in NJ, CT, MA, and the Washington, D.C., Area

Patients with prostatic acinar adenocarcinoma can find comprehensive care at Regional Cancer Care Associates. Our medical oncologists and hematologists treat all kinds of cancer and blood disorders at more than 20 locations near you in New Jersey, Connecticut, Massachusetts, and the Washington, D.C., area, enabling patients to receive care close to home. Contact us to learn more or schedule a consultation with a medical oncologist.

Prostate Cancer Frequently Asked Questions

What is prostatic acinar adenocarcinoma?

Prostatic acinar adenocarcinoma is the most common form of prostate cancer. It develops in the epithelial tissue of the prostate gland. Cancer is characterized by abnormal, out-of-control cell growth.

What are the signs of prostatic acinar adenocarcinoma?

Prostate cancer often does not cause symptoms in the early stages. In later stages, it may cause problems with urination and sexual activity.

How is prostate cancer detected?

Most cases of prostatic acinar adenocarcinoma are detected with a prostate-specific antigen (PSA) blood test. After screening detects an abnormality, the diagnosis is confirmed with a digital rectal examination (DRE), medical imaging, and a prostate biopsy.

What are the risk factors for prostate cancer?

The major risk factors for prostate cancer include age, African-American or Caribbean racial heritage, and a family history of prostate cancer.

What are treatment options for prostate cancer?

The best prostate cancer treatment depends on the cancer stage and the patient’s overall health. Options offered by RCCA include active surveillance hormone therapy, immunotherapy, and chemotherapy. RCCA also provides patients with access to clinical trials and coordinates closely with patients’ surgeons and radiation oncologists.

Fight Cancer with Us

By classifying the stage of a patient’s cancer, health care providers are better equipped to form an appropriate treatment plan. If you or your loved one suspect symptoms of bladder cancer, one of our expert oncologists at Regional Cancer Care Associates can evaluate your symptoms, provide a diagnosis, and offer treatment. Schedule an appointment or learn more about bladder cancer stages by contacting us today.

RELATED ARTICLES

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.